Novo Nordisk (NVO-NYSE, $166.74) Revises Fiscal Guidance for 2023.

Posted on April 13, 2023 by Randolph McDuff — No Comments ↓

(all figures are converted from Danish Krone at the rate of 1 DK to .15 USD) Novo Nordisk management, today announced a significant upward revision to revenue and operating earnings estimates for 2023. Revenue for 2023, previously forecast to range…

Posted in Open Blog

published about 1 year ago

published over 1 year ago

published about 1 year ago

See all items from the same source

Nothing in this site constitutes investment, legal, tax or other advice and it is not to be relied upon in making any investment decision.

This site is under active development and it is nowhere near what I would consider alpha version.

Awesome Goat ߦ 2024 Follow on Twitter

Cookie policy: There are no cokies. Except for user authentication.

There are no Site Analytics. I have no idea what you do.

Visual Design is known weakness. Priority is function over form.

Popular Social Media site feeds are under development.

Thank You for using Awesome Goat.